Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Purine metabolism (mmu00230)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1190003J
15Rik
KLA  ATP  ATP+KLA
 AK004470 18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1190003J15 product:hypothetical Transthyretin/Transthyretin-related containing protein, full insert sequence. [AK004470] KLA 3.70 2.84 3.15 4.56 4.81 4.07 1.29
ATP .99 .87 1.37 1.71 5.17 19.64 3.47
KLA/ATP 3.00 3.08 3.34 3.61 9.32 19.35 12.86
1190003J
15Rik
KLA  ATP  ATP+KLA
 NM_029821 RIKEN cDNA 1190003J15 gene (1190003J15Rik), mRNA [NM_029821] KLA 4.65 3.78 3.57 5.26 6.06 5.74 1.52
ATP 1.00 .90 1.22 1.65 5.73 15.98 4.64
KLA/ATP 3.93 3.75 3.62 4.09 10.51 18.55 15.36
1700080E
11Rik
KLA  ATP  ATP+KLA
 NM_028562 RIKEN cDNA 1700080E11 gene (1700080E11Rik), mRNA [NM_028562] KLA .99 1.01 .96 1.00 1.02 1.04 1.06
ATP .96 .98 1.05 1.02 1.00 1.04 1.09
KLA/ATP 1.02 .97 1.03 1.02 1.01 1.06 1.01
2310079N
02Rik
KLA  ATP  ATP+KLA
 AK086714 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930047C07 product:RIKEN cDNA 2310079N02 gene, full insert sequence [AK086714] KLA .68 .70 .62 .74 .82 1.21 1.66
ATP .90 .87 .95 .89 .69 .60 1.58
KLA/ATP .63 .63 .70 .68 .56 .66 1.25
2310079N
02Rik
KLA  ATP  ATP+KLA
 NM_025636 RIKEN cDNA 2310079N02 gene (2310079N02Rik), mRNA [NM_025636] KLA .62 .65 .64 .62 .70 .99 1.32
ATP 1.04 .99 .98 1.14 .85 .36 .77
KLA/ATP .70 .70 .56 .74 .56 .47 .90
AK047274
KLA  ATP  ATP+KLA
 AK047274 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930044L01 product:unclassifiable, full insert sequence. [AK047274] KLA .92 .85 .90 .92 .98 .93 .92
ATP 1.03 1.11 1.07 .90 .89 .93 .94
KLA/ATP .89 .96 .94 .84 .93 .92 .92
AU021838
KLA  ATP  ATP+KLA
 AK032842 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720461H18 product:unclassifiable, full insert sequence [AK032842] KLA .87 .74 .81 .58 .51 .52 .55
ATP 1.00 1.03 1.09 .76 .43 .45 .42
KLA/ATP .81 .82 .68 .56 .38 .37 .31
Ada
KLA  ATP  ATP+KLA
 NM_007398 adenosine deaminase (Ada), mRNA [NM_007398] KLA .92 .93 .83 .92 .71 .59 .70
ATP .90 .91 1.24 1.79 1.48 .91 .43
KLA/ATP .82 .96 1.18 1.41 1.49 .78 .32
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy10
KLA  ATP  ATP+KLA
 NM_173029 adenylate cyclase 10 (Adcy10), mRNA [NM_173029] KLA 1.01 1.02 .96 .94 .92 .95 1.01
ATP 1.01 .97 1.04 1.05 .97 .98 .98
KLA/ATP .98 1.01 .82 1.04 .95 .98 .94
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adk
KLA  ATP  ATP+KLA
 NM_134079 adenosine kinase (Adk), mRNA [NM_134079] KLA .96 .94 .92 .79 .64 .45 .97
ATP 1.06 1.01 1.34 1.13 1.15 .97 .51
KLA/ATP .86 .94 1.22 .96 .85 .76 .32
Adsl
KLA  ATP  ATP+KLA
 NM_009634 adenylosuccinate lyase (Adsl), mRNA [NM_009634] KLA .87 .93 .90 .97 .82 .64 1.06
ATP 1.08 1.12 1.06 1.04 .80 .60 .86
KLA/ATP 1.02 .95 1.00 .86 .66 .49 .49
Adss
KLA  ATP  ATP+KLA
 NM_007422 adenylosuccinate synthetase, non muscle (Adss), mRNA [NM_007422] KLA 1.21 1.15 .96 .70 .35 .24 .51
ATP .93 1.08 .97 1.14 .93 .75 .47
KLA/ATP 1.24 1.19 .87 .99 .56 .40 .33
Adssl1
KLA  ATP  ATP+KLA
 NM_007421 adenylosuccinate synthetase like 1 (Adssl1), mRNA [NM_007421] KLA .67 .67 .53 .51 .32 .17 .20
ATP .87 .76 .96 .74 .73 .38 .60
KLA/ATP .58 .59 .64 .48 .62 .49 .37
Ak1
KLA  ATP  ATP+KLA
 NM_021515 adenylate kinase 1 (Ak1), mRNA [NM_021515] KLA .81 .81 .75 .72 .58 .46 .29
ATP .96 1.11 1.07 1.35 1.10 .69 .68
KLA/ATP .81 .89 .83 1.08 .89 .59 .46
Ak2
KLA  ATP  ATP+KLA
 NM_016895 adenylate kinase 2 (Ak2), transcript variant 2, mRNA [NM_016895] KLA 1.50 1.55 1.69 1.55 1.64 1.56 1.85
ATP 1.13 1.11 1.16 1.44 1.46 1.66 1.40
KLA/ATP 1.70 1.81 2.01 1.94 1.81 1.51 1.96
Ak3l1
KLA  ATP  ATP+KLA
 NM_009647 adenylate kinase 3 alpha-like 1 (Ak3l1), nuclear gene encoding mitochondrial protein, mRNA [NM_009647] KLA 2.47 2.87 2.76 2.37 2.11 1.57 2.16
ATP .97 1.03 1.13 1.13 1.98 3.05 1.11
KLA/ATP 2.67 2.98 2.40 2.27 2.78 2.30 1.22
Ak5
KLA  ATP  ATP+KLA
 NM_001081277 adenylate kinase 5 (Ak5), mRNA [NM_001081277] KLA 1.03 1.01 .98 1.03 .99 1.05 .97
ATP .97 1.01 1.03 .98 .99 .97 1.01
KLA/ATP .97 .96 1.08 .99 .98 .95 1.01
Ak7
KLA  ATP  ATP+KLA
 AK029555 adult male testis cDNA, RIKEN full-length enriched library, clone:4921526N12 product:hypothetical Adenylate kinase containing protein, full insert sequence [AK029555] KLA .97 .98 .99 1.03 .98 .98 1.04
ATP 1.04 .99 1.05 1.01 1.05 1.07 1.01
KLA/ATP 1.05 1.00 1.00 1.02 1.14 1.49 1.13
Allc
KLA  ATP  ATP+KLA
 AF278712 allantoicase mRNA, complete cds [AF278712] KLA 1.00 1.01 .95 1.01 1.10 1.05 1.01
ATP 1.00 1.05 1.05 1.04 1.04 1.10 .99
KLA/ATP .99 .94 1.14 1.04 1.10 1.00 1.05
Ampd1
KLA  ATP  ATP+KLA
 NM_001033303 adenosine monophosphate deaminase 1 (isoform M) (Ampd1), mRNA [NM_001033303] KLA 1.16 1.10 1.14 1.19 1.09 1.15 1.15
ATP .98 .96 1.45 4.08 3.21 2.03 1.20
KLA/ATP 1.21 1.17 1.71 3.85 3.43 2.96 1.55
Ampd2
KLA  ATP  ATP+KLA
 NM_028779 adenosine monophosphate deaminase 2 (isoform L) (Ampd2), mRNA [NM_028779] KLA .81 .66 .53 .41 .43 .60 .87
ATP .91 .83 .96 .74 .82 1.00 1.04
KLA/ATP .72 .66 .66 .48 .67 .57 .48
Ampd3
KLA  ATP  ATP+KLA
 NM_009667 AMP deaminase 3 (Ampd3), mRNA [NM_009667] KLA 1.30 1.21 1.06 .72 .73 .81 1.16
ATP 1.07 1.16 1.00 1.22 2.65 2.99 1.80
KLA/ATP 1.38 1.30 .96 .91 .90 2.18 2.05
Aprt
KLA  ATP  ATP+KLA
 M11310 gb|Mouse adenine phosphoribosyltransferase (APRT), complete cds [M11310] KLA .70 .70 .57 .69 .71 .78 1.14
ATP .88 .63 .44 .81 .63 .73 1.24
KLA/ATP .76 .59 .49 .67 .67 .68 .93
Aprt
KLA  ATP  ATP+KLA
 NM_009698 adenine phosphoribosyl transferase (Aprt), mRNA [NM_009698] KLA .74 .70 .73 .69 .64 .65 1.02
ATP 1.17 1.10 .90 1.10 .98 .66 1.42
KLA/ATP .84 .81 .70 .75 .73 .60 .95
Atic
KLA  ATP  ATP+KLA
 NM_026195 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (Atic), mRNA [NM_026195] KLA .86 .91 .91 .70 .63 .49 .77
ATP 1.16 1.33 1.00 1.41 .87 .41 .59
KLA/ATP 1.07 1.15 .70 1.01 .57 .31 .26
Cant1
KLA  ATP  ATP+KLA
 NM_029502 calcium activated nucleotidase 1 (Cant1), transcript variant 1, mRNA [NM_029502] KLA 1.11 1.12 1.26 1.22 1.42 1.72 1.45
ATP 1.08 1.14 1.00 1.15 .90 1.29 1.86
KLA/ATP 1.16 1.19 .95 1.10 .91 1.42 2.79
Dck
KLA  ATP  ATP+KLA
 NM_007832 deoxycytidine kinase (Dck), mRNA [NM_007832] KLA 2.69 2.67 3.17 3.00 3.16 3.18 2.10
ATP 1.15 1.32 1.25 1.48 1.19 3.17 1.47
KLA/ATP 2.71 2.88 2.59 4.36 3.64 4.49 3.08
Dguok
KLA  ATP  ATP+KLA
 NM_013764 deoxyguanosine kinase (Dguok), nuclear gene encoding mitochondrial protein, mRNA [NM_013764] KLA .83 .71 .91 .93 1.12 1.27 .96
ATP 1.13 .93 1.13 1.04 .65 .51 .91
KLA/ATP .81 .79 1.05 .80 .90 .68 .86
Enpp1
KLA  ATP  ATP+KLA
 ENSMUST00000105520 ens|Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E- NPP 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) (Lymphocyte antigen 41) (Ly-41) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1 KLA .71 .79 .64 .61 .55 .51 .32
ATP .85 .97 .85 .72 .62 .45 .28
KLA/ATP .72 .73 .61 .66 .60 .55 .27
Enpp1
KLA  ATP  ATP+KLA
 NM_008813 ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1), mRNA [NM_008813] KLA .82 .83 .77 .83 .65 .64 .51
ATP .89 .90 1.21 1.00 .98 .87 .64
KLA/ATP .72 .76 .96 .87 1.00 .94 .51
Enpp3
KLA  ATP  ATP+KLA
 BC005527 ectonucleotide pyrophosphatase [BC005527] KLA 1.06 .99 .98 1.01 .97 .99 .96
ATP .93 1.08 .99 1.05 .94 1.05 1.10
KLA/ATP .95 .96 1.10 .99 .95 .94 1.03
Enpp3
KLA  ATP  ATP+KLA
 BC006944 ectonucleotide pyrophosphatase/phosphodiesterase 3, mRNA (cDNA clone IMAGE:2655671), complete cds. [BC006944] KLA 1.02 1.01 1.03 1.08 1.04 1.01 1.01
ATP .97 1.01 .96 1.00 .98 1.07 .99
KLA/ATP 1.01 .99 1.07 1.02 .97 .98 .92
Enpp3
KLA  ATP  ATP+KLA
 NM_134005 ectonucleotide pyrophosphatase/phosphodiesterase 3 (Enpp3), mRNA [NM_134005] KLA 1.01 .95 .99 .98 1.05 1.04 .98
ATP .98 .98 1.03 .98 .96 1.00 .98
KLA/ATP .97 1.03 1.04 .93 1.02 .99 1.04
Entpd1
KLA  ATP  ATP+KLA
 NM_009848 ectonucleoside triphosphate diphosphohydrolase 1 (Entpd1), mRNA [NM_009848] KLA .75 .72 .77 .64 .57 .42 .24
ATP 1.21 1.24 1.23 1.59 1.14 .70 1.33
KLA/ATP .87 .91 .78 1.03 .64 .66 1.14
Entpd2
KLA  ATP  ATP+KLA
 NM_009849 ectonucleoside triphosphate diphosphohydrolase 2 (Entpd2), mRNA [NM_009849] KLA .93 .98 1.00 1.04 .95 .96 1.01
ATP 1.00 .99 1.05 1.04 1.07 .89 .96
KLA/ATP .98 .98 1.06 .98 1.03 .90 1.00
Entpd3
KLA  ATP  ATP+KLA
 NM_178676 ectonucleoside triphosphate diphosphohydrolase 3 (Entpd3), mRNA [NM_178676] KLA .98 1.01 .99 .97 1.05 1.00 .99
ATP 1.02 1.02 .99 1.07 1.02 .99 1.28
KLA/ATP 1.00 1.03 1.00 1.06 1.07 1.11 1.27
Entpd4
KLA  ATP  ATP+KLA
 NM_026174 ectonucleoside triphosphate diphosphohydrolase 4 (Entpd4), mRNA [NM_026174] KLA .89 .83 .82 .74 .67 .78 .92
ATP .97 1.05 .92 .87 .71 .69 .92
KLA/ATP .86 .83 .73 .73 .61 .73 .78
Entpd5
KLA  ATP  ATP+KLA
 NM_001026214 ectonucleoside triphosphate diphosphohydrolase 5 (Entpd5), transcript variant 2, mRNA [NM_001026214] KLA .93 .98 .90 .82 .69 .55 .55
ATP .94 .99 1.15 1.08 .99 1.02 2.14
KLA/ATP .90 .97 1.04 .91 .79 .71 1.38
Entpd6
KLA  ATP  ATP+KLA
 AK030789 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830401O07 product:ectonucleoside triphosphate diphosphohydrolase 6, full insert sequence [AK030789] KLA .79 .81 .65 .72 .78 .79 .90
ATP 1.11 .98 .66 .69 .74 .72 .84
KLA/ATP .81 .74 .65 .68 .79 .67 .67
Entpd6
KLA  ATP  ATP+KLA
 NM_172117 ectonucleoside triphosphate diphosphohydrolase 6 (Entpd6), mRNA [NM_172117] KLA .84 .79 .70 .68 .73 .88 1.18
ATP 1.07 1.19 .69 .70 .48 .57 1.21
KLA/ATP .83 .81 .57 .63 .48 .68 .80
Entpd8
KLA  ATP  ATP+KLA
 NM_028093 ectonucleoside triphosphate diphosphohydrolase 8 (Entpd8), mRNA [NM_028093] KLA 1.05 .98 1.07 .98 .96 .99 1.01
ATP 1.05 1.01 .91 1.04 1.07 1.01 .90
KLA/ATP .97 1.07 1.04 1.01 .99 1.07 .99
Fhit
KLA  ATP  ATP+KLA
 NM_010210 fragile histidine triad gene (Fhit), mRNA [NM_010210] KLA 1.16 1.14 1.22 1.10 .91 .82 .65
ATP .99 1.04 1.10 1.38 1.12 .81 .50
KLA/ATP 1.14 1.21 1.11 1.20 .96 .80 .54
Gart
KLA  ATP  ATP+KLA
 AK168445 13 days embryo liver cDNA, RIKEN full-length enriched library, clone:I920021A03 product:phosphoribosylglycinamide formyltransferase, full insert sequence. [AK168445] KLA .88 .80 .73 .71 .52 .48 .75
ATP 1.03 .98 1.11 1.02 .61 .37 .52
KLA/ATP .81 .86 .87 .75 .49 .30 .26
Gart
KLA  ATP  ATP+KLA
 NM_010256 phosphoribosylglycinamide formyltransferase (Gart), mRNA [NM_010256] KLA .68 .73 .60 .50 .46 .57 .70
ATP .97 1.03 .93 .91 .59 .39 .58
KLA/ATP .69 .70 .58 .59 .39 .32 .33
Gda
KLA  ATP  ATP+KLA
 NM_010266 guanine deaminase (Gda), mRNA [NM_010266] KLA 3.01 3.35 3.91 4.08 3.78 1.70 1.21
ATP 1.05 1.05 1.15 1.13 1.25 1.99 1.32
KLA/ATP 3.04 3.63 3.25 3.16 2.29 1.87 1.59
Gmpr
KLA  ATP  ATP+KLA
 NM_025508 guanosine monophosphate reductase (Gmpr), mRNA [NM_025508] KLA .68 .67 .61 .55 .42 .40 .36
ATP .92 .93 1.21 1.10 .75 .41 .57
KLA/ATP .63 .63 .76 .69 .58 .43 .41
Gmpr2
KLA  ATP  ATP+KLA
 NM_177992 guanosine monophosphate reductase 2 (Gmpr2), mRNA [NM_177992] KLA .80 .81 .79 .70 .90 1.02 1.21
ATP .98 1.07 .95 .96 .67 .79 1.16
KLA/ATP .85 .90 .76 .79 .63 .66 .79
Gmps
KLA  ATP  ATP+KLA
 NM_001033300 guanine monphosphate synthetase (Gmps), mRNA [NM_001033300] KLA 1.04 1.13 1.05 .91 .79 .75 .96
ATP 1.12 1.17 1.01 1.24 .99 1.02 .82
KLA/ATP 1.18 1.08 .92 1.11 .86 .94 .62
Gucy1a3
KLA  ATP  ATP+KLA
 NM_021896 guanylate cyclase 1, soluble, alpha 3 (Gucy1a3), mRNA [NM_021896] KLA 1.01 1.01 1.04 .99 .99 .97 .99
ATP .99 1.01 .99 .99 .97 1.02 1.02
KLA/ATP 1.00 .96 1.00 .99 .98 1.04 .99
Gucy1b2
KLA  ATP  ATP+KLA
 NM_172810 guanylate cyclase 1, soluble, beta 2 (Gucy1b2), mRNA [NM_172810] KLA 1.02 1.03 1.03 1.09 .95 1.06 .91
ATP 1.01 1.03 1.01 1.08 .96 1.04 .90
KLA/ATP 1.04 1.03 .99 1.05 .97 .96 .84
Gucy1b3
KLA  ATP  ATP+KLA
 NM_017469 guanylate cyclase 1, soluble, beta 3 (Gucy1b3), mRNA [NM_017469] KLA .99 .99 .99 1.01 .98 .98 1.00
ATP .98 .98 .98 .98 .98 1.00 1.01
KLA/ATP .96 .99 .98 1.01 .99 .99 .99
Gucy2c
KLA  ATP  ATP+KLA
 NM_145067 guanylate cyclase 2c (Gucy2c), mRNA [NM_145067] KLA .97 1.08 1.02 1.02 1.09 1.07 1.11
ATP .97 1.01 1.09 1.09 1.00 1.09 .98
KLA/ATP .97 1.06 .98 1.15 1.06 1.14 1.15
Gucy2e
KLA  ATP  ATP+KLA
 BC057954 guanylate cyclase 2e, mRNA (cDNA clone MGC:68216 IMAGE:5360206), complete cds. [BC057954] KLA 1.04 .98 .97 1.00 1.00 .98 .95
ATP 1.04 1.01 .96 .98 .95 1.03 1.01
KLA/ATP 1.00 .98 1.04 .98 1.00 1.01 1.07
Gucy2e
KLA  ATP  ATP+KLA
 NM_008192 guanylate cyclase 2e (Gucy2e), mRNA [NM_008192] KLA 1.02 1.04 1.01 1.04 1.02 1.02 1.07
ATP .99 1.07 1.02 1.01 .98 1.05 1.05
KLA/ATP 1.03 .99 1.02 1.02 1.02 .99 1.04
Gucy2f
KLA  ATP  ATP+KLA
 NM_001007576 guanylate cyclase 2f (Gucy2f), mRNA [NM_001007576] KLA .98 .99 1.00 .93 1.00 1.01 1.02
ATP 1.00 1.02 1.05 1.08 1.03 .98 1.02
KLA/ATP 1.05 .94 .81 1.05 .97 1.10 .96
Guk1
KLA  ATP  ATP+KLA
 NM_008193 guanylate kinase 1 (Guk1), mRNA [NM_008193] KLA 1.32 1.31 1.23 1.15 1.08 .77 .77
ATP 1.09 1.09 1.12 1.12 .96 .68 1.24
KLA/ATP 1.22 1.31 1.39 1.38 1.05 .85 .87
Hddc3
KLA  ATP  ATP+KLA
 NM_026812 HD domain containing 3 (Hddc3), mRNA [NM_026812] KLA .87 .88 .82 .78 .75 .74 .93
ATP 1.08 1.11 .99 .92 .87 .75 .91
KLA/ATP .83 .89 .87 .77 .80 .74 .86
Hprt1
KLA  ATP  ATP+KLA
 NM_013556 hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1), mRNA [NM_013556] KLA .82 .77 .81 .79 .53 .43 .39
ATP .97 .89 1.40 .89 .82 .68 .25
KLA/ATP .73 .69 1.09 .68 .66 .42 .13
Impdh1
KLA  ATP  ATP+KLA
 NM_011829 inosine 5-phosphate dehydrogenase 1 (Impdh1), mRNA [NM_011829] KLA 1.03 .99 .86 .89 .71 .52 .55
ATP .89 .81 .82 .81 .90 1.01 .85
KLA/ATP .91 .79 .76 .83 .90 .99 .64
Impdh2
KLA  ATP  ATP+KLA
 NM_011830 inosine 5-phosphate dehydrogenase 2 (Impdh2), mRNA [NM_011830] KLA .88 .92 .76 .67 .48 .46 .62
ATP 1.07 1.12 .90 1.26 1.15 .82 .48
KLA/ATP .97 .98 .81 .98 .79 .61 .33
Itpa
KLA  ATP  ATP+KLA
 NM_025922 inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (Itpa), mRNA [NM_025922] KLA 1.02 .96 1.01 1.18 1.37 1.83 1.44
ATP .96 .93 1.08 .95 .92 1.66 1.38
KLA/ATP .86 .94 1.20 1.08 1.28 2.15 2.45
Mm.13558
1
KLA  ATP  ATP+KLA
 34328145 Unknown KLA .73 .64 .50 .54 .38 .49 1.02
ATP .88 .84 1.16 .94 .66 .72 .68
KLA/ATP .56 .62 .71 .49 .40 .30 .42
Mm.17932
KLA  ATP  ATP+KLA
 142368657 Unknown KLA 1.96 2.16 2.26 2.04 1.94 2.22 1.33
ATP 1.19 1.29 2.96 4.36 1.42 1.27 1.16
KLA/ATP 4.95 7.89 18.00 12.21 3.38 1.85 1.27
Mm.21511
5
KLA  ATP  ATP+KLA
 146149315 Unknown KLA .94 .93 .96 .95 .89 .95 1.08
ATP 1.02 .93 1.00 .83 .78 .92 1.58
KLA/ATP .90 .96 .93 .85 .77 .83 .83
Mm.24661
3
KLA  ATP  ATP+KLA
 124486645 Unknown KLA 1.04 .95 1.00 .97 1.01 1.06 1.10
ATP 1.07 1.05 1.06 .98 1.04 1.08 1.01
KLA/ATP .96 1.01 .97 1.04 1.04 1.03 1.09
Mm.29128
6
KLA  ATP  ATP+KLA
 89179305 Unknown KLA 1.03 .97 1.00 1.05 1.09 .97 .92
ATP 1.07 1.00 1.01 .96 .93 .98 .93
KLA/ATP 1.06 1.05 1.05 1.04 1.03 .96 1.04
Mm.33127
2
KLA  ATP  ATP+KLA
 114431239 Unknown KLA 1.20 1.18 1.18 1.16 1.18 1.25 1.20
ATP 1.02 1.00 2.55 17.57 7.98 3.58 1.31
KLA/ATP 1.29 1.24 3.14 14.38 12.37 7.20 2.04
Mm.3458
KLA  ATP  ATP+KLA
 119226250 Unknown KLA .85 .78 .75 .84 .74 .81 .79
ATP .97 .83 1.09 .93 2.03 1.96 .89
KLA/ATP .81 .72 .89 .63 1.72 1.77 .79
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.42040
KLA  ATP  ATP+KLA
 146149300 Unknown KLA 7.51 8.44 6.42 6.50 4.95 2.64 3.74
ATP .91 .86 1.41 1.06 5.00 13.26 .50
KLA/ATP 7.10 8.32 10.08 6.10 13.81 8.56 1.67
Mm.43970
2
KLA  ATP  ATP+KLA
 38327645 Unknown KLA .89 .90 .82 .83 .70 .65 .67
ATP 1.00 .95 1.37 1.24 1.13 .76 .97
KLA/ATP .87 .88 1.23 .98 1.02 .64 .36
Mm.45856
3
KLA  ATP  ATP+KLA
 142351405 Unknown KLA .93 .96 .85 .74 .64 .68 .87
ATP 1.03 1.07 1.02 1.04 .94 1.01 1.14
KLA/ATP .98 .98 .75 .87 .68 1.02 1.15
Mm.47209
5
KLA  ATP  ATP+KLA
 85861217 Unknown KLA .81 .77 .71 .75 .70 .72 .87
ATP 1.08 1.12 .79 .80 .68 .62 .59
KLA/ATP .86 .83 .56 .66 .56 .63 .57
Mm.66952
KLA  ATP  ATP+KLA
 141801853 Unknown KLA .86 .94 .99 .93 1.03 .95 1.06
ATP 1.04 .91 1.01 1.11 1.03 1.03 1.07
KLA/ATP .91 .94 .90 .88 .99 .98 1.12
Mm.79179
KLA  ATP  ATP+KLA
 141803280 Unknown KLA .95 1.09 1.04 1.13 1.00 1.10 .98
ATP 1.02 1.17 1.04 1.18 1.06 1.02 1.01
KLA/ATP .98 1.00 1.02 1.01 .98 .93 .99
Nme1
KLA  ATP  ATP+KLA
 NM_008704 non-metastatic cells 1, protein (NM23A) expressed in (Nme1), mRNA [NM_008704] KLA .82 .85 .74 .76 .64 .62 .69
ATP .92 .94 1.26 1.20 1.08 .69 1.01
KLA/ATP .78 .84 1.03 .91 .92 .60 .31
Nme2
KLA  ATP  ATP+KLA
 NM_001077529 non-metastatic cells 2, protein (NM23B) expressed in (Nme2), transcript variant 2, mRNA [NM_001077529] KLA .96 .98 .93 .97 .84 .87 .80
ATP .97 .89 1.13 1.04 1.05 1.08 .56
KLA/ATP .95 .95 1.07 1.10 1.06 1.02 .53
Nme3
KLA  ATP  ATP+KLA
 NM_019730 non-metastatic cells 3, protein expressed in (Nme3), mRNA [NM_019730] KLA .74 .77 .74 .64 .53 .37 .29
ATP 1.03 1.05 1.14 1.30 1.07 .75 .75
KLA/ATP .79 .82 .84 1.01 .84 .64 .44
Nme4
KLA  ATP  ATP+KLA
 NM_019731 non-metastatic cells 4, protein expressed in (Nme4), mRNA [NM_019731] KLA .85 .85 .78 .75 .68 .56 .61
ATP .98 1.09 1.08 1.37 .89 .43 .43
KLA/ATP .89 .84 .76 1.08 .70 .48 .26
Nme5
KLA  ATP  ATP+KLA
 NM_080637 non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (Nme5), mRNA [NM_080637] KLA .96 1.00 .99 1.00 1.03 1.02 1.02
ATP 1.01 1.05 1.04 1.03 1.00 1.00 1.05
KLA/ATP 1.06 .98 1.00 .95 1.03 .98 1.05
Nme6
KLA  ATP  ATP+KLA
 NM_018757 non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) (Nme6), mRNA [NM_018757] KLA .72 .79 .85 .86 .96 1.12 1.75
ATP .94 .95 1.01 .97 .65 .71 .95
KLA/ATP .77 .77 .73 .77 .63 .63 .95
Nme7
KLA  ATP  ATP+KLA
 NM_138314 non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) (Nme7), transcript variant 1, mRNA [NM_138314] KLA .78 .77 .80 .93 1.07 1.28 .98
ATP .95 .89 1.00 .88 .63 1.11 1.22
KLA/ATP .73 .77 .81 .72 .77 1.83 1.30
Npr1
KLA  ATP  ATP+KLA
 NM_008727 natriuretic peptide receptor 1 (Npr1), mRNA [NM_008727] KLA 1.01 .99 .99 1.06 1.12 .99 1.05
ATP .99 .95 .99 1.01 .96 1.02 1.07
KLA/ATP 1.03 1.05 .99 1.03 1.07 .99 1.03
Npr2
KLA  ATP  ATP+KLA
 NM_173788 natriuretic peptide receptor 2 (Npr2), mRNA [NM_173788] KLA 1.09 1.04 1.09 1.17 1.10 1.02 .94
ATP 1.00 .99 1.10 1.10 1.11 1.08 .90
KLA/ATP 1.07 1.06 1.39 1.16 1.19 1.08 1.00
Nt5c
KLA  ATP  ATP+KLA
 NM_015807 5,3-nucleotidase, cytosolic (Nt5c), mRNA [NM_015807] KLA .81 .85 .74 .73 .75 .83 1.14
ATP .94 .90 .95 .96 .58 .52 1.07
KLA/ATP .78 .79 .82 .88 .65 .43 .68
Nt5c1b
KLA  ATP  ATP+KLA
 NM_027588 5-nucleotidase, cytosolic IB (Nt5c1b), mRNA [NM_027588] KLA 1.00 .98 .99 .99 1.00 1.02 1.00
ATP .98 1.02 1.01 .99 1.02 1.00 .94
KLA/ATP 1.01 1.02 .90 1.00 1.09 1.02 1.05
Nt5c2
KLA  ATP  ATP+KLA
 NM_029810 5-nucleotidase, cytosolic II (Nt5c2), mRNA [NM_029810] KLA .68 .66 .66 .62 .73 1.00 .79
ATP .98 1.02 1.06 .95 .65 .73 1.16
KLA/ATP .66 .68 .67 .61 .57 .80 1.07
Nt5c3
KLA  ATP  ATP+KLA
 NM_026004 5-nucleotidase, cytosolic III (Nt5c3), mRNA [NM_026004] KLA 19.31 19.80 19.18 17.01 11.84 11.21 4.96
ATP .98 .97 1.14 1.55 2.72 4.79 2.27
KLA/ATP 18.71 19.81 24.58 21.68 18.82 17.51 13.49
Nt5c3l
KLA  ATP  ATP+KLA
 NM_026561 5-nucleotidase, cytosolic III-like (Nt5c3l), transcript variant 2, mRNA [NM_026561] KLA .94 .91 .95 .90 .80 .79 .91
ATP .94 1.07 1.12 1.08 .86 .71 .87
KLA/ATP .97 .97 .88 .97 .83 .77 .67
Nt5e
KLA  ATP  ATP+KLA
 NM_011851 5 nucleotidase, ecto (Nt5e), mRNA [NM_011851] KLA .96 1.02 1.00 .95 1.00 .99 .99
ATP .98 .99 1.05 1.02 1.04 1.03 1.11
KLA/ATP .97 .99 .96 .95 .96 .99 1.04
Nt5m
KLA  ATP  ATP+KLA
 NM_134029 5,3-nucleotidase, mitochondrial (Nt5m), nuclear gene encoding mitochondrial protein, mRNA [NM_134029] KLA .73 .78 .92 1.14 1.54 2.01 1.80
ATP 1.02 1.06 .94 1.05 .73 .63 1.43
KLA/ATP .73 .76 .74 .85 .77 .87 1.50
Nudt16
KLA  ATP  ATP+KLA
 NM_029385 nudix (nucleoside diphosphate linked moiety X)-type motif 16 (Nudt16), mRNA [NM_029385] KLA .74 .80 .89 .93 1.05 1.11 1.22
ATP .90 .80 .75 .75 .40 .52 1.09
KLA/ATP .68 .64 .63 .68 .48 .64 1.59
Nudt2
KLA  ATP  ATP+KLA
 NM_025539 nudix (nucleoside diphosphate linked moiety X)-type motif 2 (Nudt2), mRNA [NM_025539] KLA .94 1.01 .93 .92 .94 .87 1.00
ATP .95 1.07 1.10 1.28 .86 .59 1.13
KLA/ATP .96 .98 .97 1.23 .89 .60 .74
Nudt5
KLA  ATP  ATP+KLA
 NM_016918 nudix (nucleoside diphosphate linked moiety X)-type motif 5 (Nudt5), mRNA [NM_016918] KLA .98 1.01 1.05 .98 .81 .69 .99
ATP 1.02 .97 1.13 1.20 1.00 .62 .83
KLA/ATP .99 1.04 1.02 1.07 .91 .63 .62
Nudt9
KLA  ATP  ATP+KLA
 NM_028794 nudix (nucleoside diphosphate linked moiety X)-type motif 9 (Nudt9), mRNA [NM_028794] KLA 3.55 2.96 2.90 2.95 1.93 1.18 .91
ATP 1.02 .97 1.07 1.04 1.10 1.25 1.37
KLA/ATP 3.15 2.96 3.97 3.33 2.87 1.68 1.10
Paics
KLA  ATP  ATP+KLA
 NM_025939 phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase (Paics), mRNA [NM_025939] KLA .75 .84 .85 .62 .60 .40 .50
ATP 1.09 1.19 1.06 1.27 .94 .40 .38
KLA/ATP .87 .90 .69 .95 .57 .34 .22
Papss1
KLA  ATP  ATP+KLA
 NM_011863 3-phosphoadenosine 5-phosphosulfate synthase 1 (Papss1), mRNA [NM_011863] KLA .86 .95 .84 .89 .77 .70 .81
ATP .99 1.02 1.06 1.10 .74 .64 .75
KLA/ATP .93 .89 .86 .93 .68 .56 .69
Papss2
KLA  ATP  ATP+KLA
 AK029185 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831410G12 product:3-phosphoadenosine 5-phosphosulfate synthase 2, full insert sequence. [AK029185] KLA 1.04 1.07 .97 .95 1.08 1.07 .94
ATP .96 1.01 1.00 1.02 .96 1.01 .97
KLA/ATP .99 1.01 1.02 1.11 1.01 .98 1.02
Papss2
KLA  ATP  ATP+KLA
 NM_011864 3-phosphoadenosine 5-phosphosulfate synthase 2 (Papss2), mRNA [NM_011864] KLA 1.72 1.84 1.85 1.50 1.56 1.01 1.14
ATP 1.07 1.14 1.07 1.00 1.19 1.75 1.07
KLA/ATP 1.64 1.73 1.57 1.58 1.46 1.54 1.10
Pde10a
KLA  ATP  ATP+KLA
 NM_011866 phosphodiesterase 10A (Pde10a), mRNA [NM_011866] KLA 1.21 1.38 1.60 1.46 1.52 1.57 2.00
ATP 1.06 1.04 1.06 1.09 1.01 1.28 1.30
KLA/ATP 1.31 1.40 1.33 1.15 1.27 1.63 3.52
Pde11a
KLA  ATP  ATP+KLA
 AK018171 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330414F14 product:unclassifiable, full insert sequence. [AK018171] KLA .95 .95 .99 .95 1.00 1.03 .96
ATP .95 .96 .97 .95 1.03 1.00 1.01
KLA/ATP .95 1.00 1.00 .97 .97 .98 .91
Pde11a
KLA  ATP  ATP+KLA
 NM_001081033 phosphodiesterase 11A (Pde11a), mRNA [NM_001081033] KLA 1.00 1.01 1.00 1.06 1.03 1.02 1.01
ATP .97 1.03 1.02 .98 .96 1.02 1.05
KLA/ATP .99 .97 1.02 .98 1.04 .96 1.05
Pde1a
KLA  ATP  ATP+KLA
 NM_001009978 phosphodiesterase 1A, calmodulin-dependent (Pde1a), transcript variant 7, mRNA [NM_001009978] KLA 1.42 1.46 1.58 1.35 1.43 1.21 1.25
ATP 1.02 1.01 1.07 1.13 1.50 1.46 1.08
KLA/ATP 1.44 1.52 1.27 1.38 1.23 1.40 1.41
Pde1a
KLA  ATP  ATP+KLA
 NM_016744 phosphodiesterase 1A, calmodulin-dependent (Pde1a), mRNA [NM_016744] KLA .98 .99 1.03 1.04 1.02 .96 1.04
ATP 1.02 1.02 1.05 1.03 1.00 .98 .98
KLA/ATP .99 1.00 1.08 1.03 1.01 1.04 1.00
Pde1b
KLA  ATP  ATP+KLA
 NM_008800 phosphodiesterase 1B, Ca2+-calmodulin dependent (Pde1b), mRNA [NM_008800] KLA 1.53 1.78 1.80 1.94 2.87 2.77 1.81
ATP 1.16 1.04 .98 1.15 1.27 1.30 .81
KLA/ATP 1.71 1.80 1.46 1.38 1.25 1.92 2.12
Pde1c
KLA  ATP  ATP+KLA
 ENSMUST00000114327 ens|Calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase 1C (EC 3.1.4.17) (Cam-PDE 1C). [Source:Uniprot/SWISSPROT;Acc:Q64338] [ENSMUST00000114327] KLA .94 1.03 1.01 .96 1.09 1.05 1.04
ATP 1.06 1.04 1.02 1.04 1.02 1.03 .96
KLA/ATP .93 .96 .99 1.11 1.04 1.08 1.01
Pde1c
KLA  ATP  ATP+KLA
 NM_001025568 phosphodiesterase 1C (Pde1c), transcript variant 2, mRNA [NM_001025568] KLA .90 .87 .88 .83 .73 .72 .74
ATP .93 1.03 1.06 .92 .88 .78 .74
KLA/ATP .96 .94 .95 .91 .84 .72 .72
Pde1c
KLA  ATP  ATP+KLA
 NM_011054 phosphodiesterase 1C (Pde1c), transcript variant 1, mRNA [NM_011054] KLA .96 .98 .90 .96 .91 1.01 .93
ATP .93 .95 .99 .94 .94 .92 .95
KLA/ATP 1.00 .91 .81 1.05 1.01 .88 .88
Pde2a
KLA  ATP  ATP+KLA
 NM_001008548 phosphodiesterase 2A, cGMP-stimulated (Pde2a), mRNA [NM_001008548] KLA 1.34 1.57 1.59 1.45 1.68 1.86 1.20
ATP 1.06 1.14 1.01 1.25 4.20 4.27 1.53
KLA/ATP 1.66 1.63 1.30 1.68 3.03 3.15 1.87
Pde3a
KLA  ATP  ATP+KLA
 AK004638 adult male lung cDNA, RIKEN full-length enriched library, clone:1200007J10 product:phosphodiesterase 3A, cGMP inhibited, full insert sequence. [AK004638] KLA .96 .94 .95 1.07 1.01 1.00 1.03
ATP 1.02 .95 .96 1.07 .97 .96 1.01
KLA/ATP 1.00 1.00 1.02 .94 .98 .99 1.01
Pde3a
KLA  ATP  ATP+KLA
 AK052718 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630035A07 product:inferred: phosphodiesterase 3A, cGMP inhibited, full insert sequence. [AK052718] KLA .93 1.02 .94 1.00 .98 1.03 .96
ATP 1.03 .96 1.00 .98 1.00 1.03 1.01
KLA/ATP .98 1.06 1.08 1.03 .94 .98 .89
Pde3a
KLA  ATP  ATP+KLA
 NM_018779 phosphodiesterase 3A, cGMP inhibited (Pde3a), mRNA [NM_018779] KLA 1.01 1.09 .98 .98 .93 1.03 1.09
ATP .99 .97 1.04 1.05 .96 .96 1.06
KLA/ATP 1.06 .97 .94 1.09 1.00 1.06 .96
Pde3b
KLA  ATP  ATP+KLA
 AK044183 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097M14 product:phosphodiesterase 3B, cGMP-inhibited, full insert sequence. [AK044183] KLA .98 .99 1.04 .99 .93 1.01 .96
ATP 1.08 .96 .92 .93 .93 .90 .93
KLA/ATP .97 .94 .95 .89 .92 .89 .95
Pde3b
KLA  ATP  ATP+KLA
 NM_011055 phosphodiesterase 3B, cGMP-inhibited (Pde3b), mRNA [NM_011055] KLA 1.02 1.01 .95 1.00 .88 .75 .59
ATP 1.12 1.20 1.09 1.04 .71 .95 .81
KLA/ATP .90 .92 1.00 .94 .74 .85 .93
Pde4a
KLA  ATP  ATP+KLA
 BC044786 phosphodiesterase 4A, cAMP specific, mRNA (cDNA clone IMAGE:5062421), complete cds. [BC044786] KLA 1.03 1.01 1.05 1.12 1.06 1.10 1.05
ATP .98 1.00 .94 1.05 1.06 .99 .97
KLA/ATP 1.01 1.04 1.02 1.07 1.11 .99 1.01
Pde4a
KLA  ATP  ATP+KLA
 NM_183408 phosphodiesterase 4A, cAMP specific (Pde4a), transcript variant 5, mRNA [NM_183408] KLA 1.28 1.05 .94 .98 .78 .68 .61
ATP 1.12 .93 1.04 .81 .44 .51 .55
KLA/ATP 1.21 1.15 1.35 .88 .65 .50 .40
Pde4b
KLA  ATP  ATP+KLA
 AK171700 activated spleen cDNA, RIKEN full-length enriched library, clone:F830005J09 product:phosphodiesterase 4B, cAMP specific, full insert sequence. [AK171700] KLA 25.30 22.34 17.69 20.47 19.25 9.46 8.13
ATP 1.84 2.56 6.89 13.77 29.40 29.52 2.02
KLA/ATP 28.05 34.82 40.94 18.74 13.88 20.46 9.76
Pde4b
KLA  ATP  ATP+KLA
 NM_019840 phosphodiesterase 4B, cAMP specific (Pde4b), mRNA [NM_019840] KLA 26.82 26.37 24.04 25.17 23.52 15.22 11.94
ATP .98 1.46 3.13 12.73 25.11 31.06 3.63
KLA/ATP 25.32 28.44 32.37 35.94 25.49 29.74 21.61
Pde4c
KLA  ATP  ATP+KLA
 NM_201607 phosphodiesterase 4C, cAMP specific (Pde4c), mRNA [NM_201607] KLA .84 .85 .87 .93 .98 .82 .87
ATP 1.07 1.02 1.34 1.24 1.14 .83 .90
KLA/ATP .94 .91 1.00 1.23 1.06 .87 .94
Pde5a
KLA  ATP  ATP+KLA
 NM_153422 phosphodiesterase 5A, cGMP-specific (Pde5a), mRNA [NM_153422] KLA 1.01 .98 1.05 1.03 1.11 1.01 1.17
ATP 1.02 1.01 .97 1.04 .97 1.61 1.19
KLA/ATP 1.08 .99 .92 1.08 1.10 1.48 3.09
Pde6a
KLA  ATP  ATP+KLA
 NM_146086 phosphodiesterase 6A, cGMP-specific, rod, alpha (Pde6a), mRNA [NM_146086] KLA 1.06 1.01 1.04 .97 .98 .97 .94
ATP 1.01 .97 1.06 .95 1.02 1.01 .95
KLA/ATP .95 1.04 1.06 .94 1.08 .98 1.02
Pde6b
KLA  ATP  ATP+KLA
 NM_008806 phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide (Pde6b), mRNA [NM_008806] KLA 1.08 1.07 1.14 1.15 1.24 1.33 1.14
ATP 1.07 .89 1.06 1.12 1.03 .99 1.02
KLA/ATP 1.06 1.11 1.01 1.07 1.05 1.12 1.10
Pde6c
KLA  ATP  ATP+KLA
 NM_033614 phosphodiesterase 6C, cGMP specific, cone, alpha prime (Pde6c), mRNA [NM_033614] KLA 1.01 .99 1.00 .93 .96 .93 .95
ATP 1.07 1.05 .95 .97 .97 1.03 .95
KLA/ATP .96 1.00 1.04 .98 1.01 .96 1.00
Pde6d
KLA  ATP  ATP+KLA
 NM_008801 phosphodiesterase 6D, cGMP-specific, rod, delta (Pde6d), mRNA [NM_008801] KLA .96 .99 1.07 .95 1.14 1.22 1.22
ATP 1.06 1.09 1.09 1.13 .71 .41 1.17
KLA/ATP 1.06 .97 1.06 1.13 .83 .54 1.44
Pde6g
KLA  ATP  ATP+KLA
 NM_012065 phosphodiesterase 6G, cGMP-specific, rod, gamma (Pde6g), mRNA [NM_012065] KLA 1.23 1.11 1.17 1.10 1.21 1.09 1.11
ATP 1.06 1.00 1.10 .99 .94 .97 .90
KLA/ATP 1.14 1.23 1.10 1.44 1.04 .91 1.13
Pde6h
KLA  ATP  ATP+KLA
 NM_023898 phosphodiesterase 6H, cGMP-specific, cone, gamma (Pde6h), mRNA [NM_023898] KLA 1.05 1.04 1.02 .96 .96 1.06 .89
ATP .98 .93 .98 .82 .78 .89 .93
KLA/ATP .96 .96 .96 .88 .90 .93 .85
Pde7a
KLA  ATP  ATP+KLA
 NM_008802 phosphodiesterase 7A (Pde7a), transcript variant 1, mRNA [NM_008802] KLA 1.53 1.59 2.57 2.03 1.20 .99 .77
ATP 1.03 1.01 .96 .77 .98 .95 1.15
KLA/ATP 1.60 1.68 1.85 1.72 1.33 1.12 .93
Pde8a
KLA  ATP  ATP+KLA
 AK148238 B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370062O07 product:phosphodiesterase 8A, full insert sequence [AK148238] KLA .49 .45 .39 .28 .30 .59 .86
ATP 1.04 1.20 .95 1.33 .80 1.03 1.53
KLA/ATP .50 .46 .28 .48 .42 .82 1.36
Pde8b
KLA  ATP  ATP+KLA
 AK034510 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330209J16 product:unclassifiable, full insert sequence. [AK034510] KLA .80 .82 .79 .81 .89 .89 .83
ATP 1.06 .97 .79 .80 .88 .78 .79
KLA/ATP .81 .80 .79 .78 .92 .90 .71
Pde8b
KLA  ATP  ATP+KLA
 NM_172263 phosphodiesterase 8B (Pde8b), mRNA [NM_172263] KLA .87 .86 .84 .84 .81 1.03 1.36
ATP .99 .90 .94 .77 .71 1.09 1.33
KLA/ATP .89 .93 .85 .76 .69 .94 1.37
Pde9a
KLA  ATP  ATP+KLA
 NM_008804 phosphodiesterase 9A (Pde9a), mRNA [NM_008804] KLA .99 1.04 1.04 .99 1.02 1.04 1.04
ATP 1.05 1.32 1.03 1.05 1.08 1.02 1.03
KLA/ATP .97 1.01 .89 .98 .99 .99 .99
Pgm1
KLA  ATP  ATP+KLA
 NM_025700 phosphoglucomutase 1 (Pgm1), mRNA [NM_025700] KLA 1.08 1.03 .95 .75 .59 .55 .73
ATP 1.02 1.23 1.22 1.42 1.07 .75 1.01
KLA/ATP 1.01 1.10 .84 1.12 .69 .61 .51
Pgm2
KLA  ATP  ATP+KLA
 NM_028132 phosphoglucomutase 2 (Pgm2), mRNA [NM_028132] KLA 1.13 1.21 1.26 1.48 1.52 1.81 1.81
ATP .90 .92 1.07 .99 .80 1.60 1.17
KLA/ATP 1.01 1.16 1.40 1.25 1.48 1.99 1.94
Pklr
KLA  ATP  ATP+KLA
 NM_013631 pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631] KLA 1.06 1.01 1.12 1.00 .98 1.01 1.07
ATP .98 .94 1.05 1.06 1.01 1.06 1.10
KLA/ATP .97 1.00 1.04 .95 .89 1.05 .97
Pkm2
KLA  ATP  ATP+KLA
 D38379 mRNA for pyruvate kinase M, complete cds. [D38379] KLA .80 .83 .94 .67 .95 .95 1.42
ATP 1.22 1.30 .83 1.14 .99 1.23 2.53
KLA/ATP .99 1.03 .61 .83 .70 1.16 2.54
Pkm2
KLA  ATP  ATP+KLA
 NM_011099 pyruvate kinase, muscle (Pkm2), mRNA [NM_011099] KLA .84 .89 .95 .72 .92 1.03 1.34
ATP 1.05 1.23 .83 1.13 .96 1.20 2.14
KLA/ATP .98 .97 .64 .89 .73 1.20 2.32
Pnp1
KLA  ATP  ATP+KLA
 NM_013632 purine-nucleoside phosphorylase 1 (Pnp1), mRNA [NM_013632] KLA 5.68 5.47 6.37 7.13 8.25 8.23 3.96
ATP 1.15 1.04 1.14 1.52 1.68 3.22 3.33
KLA/ATP 5.61 5.86 7.11 8.09 8.18 8.72 9.32
Pnpt1
KLA  ATP  ATP+KLA
 AK085482 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630033G07 product:unclassifiable, full insert sequence. [AK085482] KLA .98 1.03 1.04 .98 1.03 1.03 1.01
ATP .97 .98 .96 1.02 .95 1.01 .98
KLA/ATP 1.02 1.08 1.01 1.00 1.00 1.06 1.03
Pnpt1
KLA  ATP  ATP+KLA
 NM_027869 polyribonucleotide nucleotidyltransferase 1 (Pnpt1), mRNA [NM_027869] KLA 3.44 3.41 4.04 3.56 2.94 2.53 2.01
ATP 1.06 1.07 1.19 1.24 .74 1.53 1.24
KLA/ATP 3.55 4.25 4.40 4.20 2.57 2.41 2.01
Pola1
KLA  ATP  ATP+KLA
 NM_008892 polymerase (DNA directed), alpha 1 (Pola1), mRNA [NM_008892] KLA .72 .68 .59 .56 .27 .19 .21
ATP .81 .97 1.41 1.22 .71 .29 .16
KLA/ATP .58 .70 .81 .56 .39 .27 .12
Pola2
KLA  ATP  ATP+KLA
 BC006945 polymerase (DNA directed), alpha 2, mRNA (cDNA clone MGC:11533 IMAGE:3602559), complete cds [BC006945] KLA .74 .76 .70 .74 .88 .91 .98
ATP .99 1.03 .83 .78 .96 .76 .92
KLA/ATP .67 .69 .65 .77 .88 .83 1.02
Pola2
KLA  ATP  ATP+KLA
 NM_008893 polymerase (DNA directed), alpha 2 (Pola2), mRNA [NM_008893] KLA .82 .76 .91 .72 .73 .74 .85
ATP 1.12 1.12 .88 1.20 .86 .82 .64
KLA/ATP .89 .84 .75 .84 .78 .91 1.16
Pold1
KLA  ATP  ATP+KLA
 NM_011131 polymerase (DNA directed), delta 1, catalytic subunit (Pold1), mRNA [NM_011131] KLA .24 .21 .20 .18 .18 .29 .36
ATP 1.05 1.05 .96 .99 .52 .26 .32
KLA/ATP .26 .22 .21 .22 .16 .17 .18
Pold2
KLA  ATP  ATP+KLA
 NM_008894 polymerase (DNA directed), delta 2, regulatory subunit (Pold2), mRNA [NM_008894] KLA .77 .83 .69 .68 .59 .49 .57
ATP 1.05 1.09 .97 1.24 .89 .44 .43
KLA/ATP .79 .78 .70 .84 .60 .41 .30
Pold3
KLA  ATP  ATP+KLA
 NM_133692 polymerase (DNA-directed), delta 3, accessory subunit (Pold3), mRNA [NM_133692] KLA 1.14 1.07 1.22 1.22 1.12 1.40 1.10
ATP .99 .95 1.17 .89 1.46 1.74 1.55
KLA/ATP 1.01 1.08 1.54 1.28 1.86 2.34 2.11
Pold4
KLA  ATP  ATP+KLA
 NM_027196 polymerase (DNA-directed), delta 4 (Pold4), mRNA [NM_027196] KLA .81 .88 .80 .78 .85 1.04 1.40
ATP .97 1.07 1.12 1.37 1.19 .86 1.27
KLA/ATP .85 .90 .89 1.07 .90 .94 1.62
Pole
KLA  ATP  ATP+KLA
 AK086490 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930032B21 product:DNA polymerase epsilon, full insert sequence. [AK086490] KLA 1.00 1.00 1.04 .96 .94 .99 1.04
ATP .97 .95 .91 .95 .97 1.06 .95
KLA/ATP .96 .93 1.00 1.01 1.08 1.02 1.01
Pole
KLA  ATP  ATP+KLA
 NM_011132 polymerase (DNA directed), epsilon (Pole), mRNA [NM_011132] KLA .50 .44 .38 .31 .25 .21 .17
ATP 1.12 1.03 1.28 .89 .68 .30 .16
KLA/ATP .45 .44 .56 .38 .30 .21 .14
Pole2
KLA  ATP  ATP+KLA
 NM_011133 polymerase (DNA directed), epsilon 2 (p59 subunit) (Pole2), mRNA [NM_011133] KLA .25 .24 .22 .21 .21 .37 .34
ATP .93 .98 1.11 1.00 .36 .30 .35
KLA/ATP .22 .22 .29 .30 .26 .28 .19
Pole3
KLA  ATP  ATP+KLA
 BC034004 polymerase (DNA directed), epsilon 3 (p17 subunit), mRNA (cDNA clone IMAGE:5117478) [BC034004] KLA .69 .72 .63 .69 .68 .81 .61
ATP .91 .86 1.29 .96 .81 .94 .51
KLA/ATP .62 .54 .85 .64 .70 .75 .44
Pole3
KLA  ATP  ATP+KLA
 NM_021498 polymerase (DNA directed), epsilon 3 (p17 subunit) (Pole3), mRNA [NM_021498] KLA 1.14 1.14 1.23 1.36 1.18 1.15 1.01
ATP 1.02 .98 1.17 1.44 1.40 1.27 1.25
KLA/ATP 1.20 1.24 1.58 1.57 1.60 1.25 1.23
Pole4
KLA  ATP  ATP+KLA
 NM_025882 polymerase (DNA-directed), epsilon 4 (p12 subunit) (Pole4), mRNA [NM_025882] KLA 1.11 1.15 1.15 1.22 1.19 1.31 1.26
ATP 1.00 .99 1.36 1.32 1.34 1.19 .98
KLA/ATP 1.02 1.15 1.58 1.47 1.52 1.10 .85
Polr1e
KLA  ATP  ATP+KLA
 NM_022811 polymerase (RNA) I polypeptide E (Polr1e), mRNA [NM_022811] KLA 1.01 1.06 .93 .81 .72 .80 1.37
ATP 1.04 1.10 1.09 1.06 .68 1.06 .85
KLA/ATP 1.15 1.13 .87 .96 .60 .72 .56
Polr2a
KLA  ATP  ATP+KLA
 NM_009089 polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), mRNA [NM_009089] KLA 1.21 1.16 1.15 1.16 1.16 1.25 1.12
ATP 1.00 1.09 1.07 1.39 1.35 1.28 1.16
KLA/ATP 1.20 1.18 1.26 1.30 1.30 1.51 1.37
Polr2b
KLA  ATP  ATP+KLA
 NM_153798 polymerase (RNA) II (DNA directed) polypeptide B (Polr2b), mRNA [NM_153798] KLA .91 .91 .92 .73 .77 .80 .83
ATP 1.09 1.18 .96 .80 .64 .75 .93
KLA/ATP 1.01 .98 .74 .74 .53 .72 .71
Polr2c
KLA  ATP  ATP+KLA
 NM_009090 polymerase (RNA) II (DNA directed) polypeptide C (Polr2c), mRNA [NM_009090] KLA 1.45 1.41 1.48 1.33 1.24 1.24 1.34
ATP .97 1.07 1.01 1.06 1.09 1.27 1.13
KLA/ATP 1.48 1.46 1.34 1.46 1.27 1.50 1.26
Polr2d
KLA  ATP  ATP+KLA
 NM_027101 polymerase (RNA) II (DNA directed) polypeptide D (Polr2d), transcript variant 2, mRNA [NM_027101] KLA .89 .90 .80 .87 .86 .94 .99
ATP .95 .95 1.15 1.05 .93 1.45 .80
KLA/ATP .81 .88 .99 .96 .99 1.33 .89
Polr2e
KLA  ATP  ATP+KLA
 AK010567 ES cells cDNA, RIKEN full-length enriched library, clone:2410021N14 product:polymerase (RNA) II (DNA directed) polypeptide E, full insert sequence. [AK010567] KLA .67 .68 .68 .56 .58 .45 .67
ATP 1.14 1.18 1.05 1.26 .91 .63 .80
KLA/ATP .80 .77 .71 .81 .75 .50 .49
Polr2e
KLA  ATP  ATP+KLA
 NM_025554 polymerase (RNA) II (DNA directed) polypeptide E (Polr2e), mRNA [NM_025554] KLA .69 .74 .69 .61 .56 .49 .70
ATP 1.00 1.06 1.02 1.20 .88 .67 .73
KLA/ATP .79 .76 .72 .80 .77 .55 .45
Polr2f
KLA  ATP  ATP+KLA
 NM_027231 polymerase (RNA) II (DNA directed) polypeptide F (Polr2f), mRNA [NM_027231] KLA 1.01 .99 .92 .94 .86 .78 .84
ATP .94 1.00 1.18 1.34 1.14 .88 .91
KLA/ATP .96 1.07 1.23 1.38 1.16 .96 .70
Polr2g
KLA  ATP  ATP+KLA
 NM_026329 polymerase (RNA) II (DNA directed) polypeptide G (Polr2g), mRNA [NM_026329] KLA 2.39 2.22 2.36 2.22 1.69 1.12 1.08
ATP .93 .91 1.27 1.12 1.19 1.43 1.23
KLA/ATP 2.24 2.26 3.23 2.51 3.15 2.36 1.54
Polr2h
KLA  ATP  ATP+KLA
 NM_145632 polymerase (RNA) II (DNA directed) polypeptide H (Polr2h), mRNA [NM_145632] KLA .80 .76 .66 .62 .73 .87 1.14
ATP .90 .91 1.01 .99 1.10 1.32 .98
KLA/ATP .68 .72 .69 .65 .90 1.01 .62
Polr2i
KLA  ATP  ATP+KLA
 NM_027259 polymerase (RNA) II (DNA directed) polypeptide I (Polr2i), mRNA [NM_027259] KLA .67 .69 .68 .78 .80 .90 .99
ATP .98 .88 1.10 .84 .77 1.13 1.17
KLA/ATP .64 .68 .85 .70 .91 1.10 1.03
Polr2j
KLA  ATP  ATP+KLA
 NM_011293 polymerase (RNA) II (DNA directed) polypeptide J (Polr2j), mRNA [NM_011293] KLA .96 .89 .88 1.01 .88 .92 .85
ATP 1.09 1.12 1.38 1.58 1.39 1.15 .89
KLA/ATP 1.05 1.05 1.46 1.33 1.51 1.25 .88
Polr2l
KLA  ATP  ATP+KLA
 XM_888022 gb|PREDICTED: Mus musculus polymerase (RNA) II (DNA directed) polypeptide L (Polr2l), mRNA [XM_888022] KLA .82 .92 .85 .82 .77 .73 .88
ATP .95 1.00 1.15 1.42 1.20 .91 .99
KLA/ATP .86 .89 1.04 1.23 1.25 .91 .59
Polr3a
KLA  ATP  ATP+KLA
 AK039440 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330043C08 product:hypothetical protein, full insert sequence. [AK039440] KLA 1.02 .94 .96 .97 1.13 .97 1.02
ATP .71 .55 .59 .69 .88 .93 .94
KLA/ATP .81 .65 .65 .80 .83 .88 .75
Polr3a
KLA  ATP  ATP+KLA
 NM_001081247 polymerase (RNA) III (DNA directed) polypeptide A (Polr3a), mRNA [NM_001081247] KLA 1.16 1.20 1.27 1.15 1.26 1.17 1.32
ATP .98 1.08 1.07 .92 .80 .99 1.26
KLA/ATP 1.22 1.30 1.18 .99 .78 1.24 1.27
Polr3b
KLA  ATP  ATP+KLA
 NM_027423 polymerase (RNA) III (DNA directed) polypeptide B (Polr3b), mRNA [NM_027423] KLA 1.03 1.05 1.02 1.07 1.11 1.15 1.05
ATP 1.09 1.15 .96 .97 .73 .75 .93
KLA/ATP 1.04 1.12 1.00 1.00 .74 .75 .77
Polr3c
KLA  ATP  ATP+KLA
 XM_131049 gb|PREDICTED: Mus musculus polymerase (RNA) III (DNA directed) polypeptide C, transcript variant 1 (Polr3c), mRNA [XM_131049] KLA 2.33 2.34 2.59 2.37 2.10 1.82 1.42
ATP 1.02 .97 1.12 1.19 .99 1.10 1.14
KLA/ATP 2.34 2.54 2.70 2.54 2.18 1.75 1.88
Polr3d
KLA  ATP  ATP+KLA
 NM_025945 polymerase (RNA) III (DNA directed) polypeptide D (Polr3d), mRNA [NM_025945] KLA 1.08 1.08 .90 .88 .98 .99 1.60
ATP .95 1.00 .94 .89 1.23 1.19 1.21
KLA/ATP 1.06 1.13 .88 .82 .68 .72 .55
Polr3e
KLA  ATP  ATP+KLA
 AK162059 adult male adrenal gland cDNA, RIKEN full-length enriched library, clone:7330401M11 product:sex-lethal interactor homolog (Drosophila), full insert sequence [AK162059] KLA .48 .46 .37 .33 .47 .53 .72
ATP 1.06 .96 .57 .49 .65 .27 .29
KLA/ATP .54 .43 .28 .37 .44 .27 .18
Polr3e
KLA  ATP  ATP+KLA
 NM_025298 polymerase (RNA) III (DNA directed) polypeptide E (Polr3e), mRNA [NM_025298] KLA .66 .69 .61 .58 .65 .72 1.37
ATP 1.01 .95 .80 .74 .58 .58 1.01
KLA/ATP .71 .69 .52 .57 .46 .42 .49
Polr3f
KLA  ATP  ATP+KLA
 NM_029763 polymerase (RNA) III (DNA directed) polypeptide F (Polr3f), mRNA [NM_029763] KLA 1.10 1.09 1.09 .98 .95 1.00 1.08
ATP 1.07 1.06 .84 .69 .72 .94 1.06
KLA/ATP 1.13 1.08 .80 .71 .70 .92 .92
Polr3g
KLA  ATP  ATP+KLA
 NM_001081176 polymerase (RNA) III (DNA directed) polypeptide G (Polr3g), mRNA [NM_001081176] KLA .51 .53 .43 .45 .41 .45 .57
ATP .90 .84 .68 .55 .54 .64 .60
KLA/ATP .51 .47 .46 .50 .48 .53 .46
Polr3gl
KLA  ATP  ATP+KLA
 NM_027241 polymerase (RNA) III (DNA directed) polypeptide G like (Polr3gl), mRNA [NM_027241] KLA .60 .51 .54 .55 .57 .70 .53
ATP .99 .86 1.08 .84 .48 .57 .69
KLA/ATP .55 .49 .64 .50 .53 .57 .67
Polr3h
KLA  ATP  ATP+KLA
 NM_030229 polymerase (RNA) III (DNA directed) polypeptide H (Polr3h), mRNA [NM_030229] KLA .89 .85 .75 .81 .76 .85 1.01
ATP .93 .81 .86 .71 .70 .93 .83
KLA/ATP .75 .78 .73 .70 .69 .76 .76
Polr3k
KLA  ATP  ATP+KLA
 NM_025901 polymerase (RNA) III (DNA directed) polypeptide K (Polr3k), mRNA [NM_025901] KLA .72 .72 .66 .69 .63 .74 .85
ATP .87 .84 1.14 .92 .64 .87 .72
KLA/ATP .65 .71 .90 .74 .65 .53 .44
Ppat
KLA  ATP  ATP+KLA
 XM_896000 gb|PREDICTED: Mus musculus phosphoribosyl pyrophosphate amidotransferase, transcript variant 3 (Ppat), mRNA [XM_896000] KLA .54 .49 .44 .40 .36 .46 .60
ATP .91 .96 1.03 .85 .83 .81 .67
KLA/ATP .49 .50 .52 .49 .65 .63 .37
Prhoxnb
KLA  ATP  ATP+KLA
 NM_001039678 parahox cluster neighbor (Prhoxnb), mRNA [NM_001039678] KLA .98 .97 1.01 .96 .96 .97 .97
ATP .97 .97 .98 1.02 1.04 1.01 1.03
KLA/ATP .99 1.05 1.01 1.01 1.00 .93 .96
Prim1
KLA  ATP  ATP+KLA
 NM_008921 DNA primase, p49 subunit (Prim1), mRNA [NM_008921] KLA .28 .26 .22 .18 .14 .24 .28
ATP .88 .80 1.35 .98 .50 .25 .26
KLA/ATP .22 .22 .33 .23 .20 .16 .10
Prim2
KLA  ATP  ATP+KLA
 NM_008922 DNA primase, p58 subunit (Prim2), mRNA [NM_008922] KLA .72 .68 .61 .54 .39 .52 .50
ATP .88 .76 .77 .64 .39 .47 .44
KLA/ATP .63 .59 .59 .44 .34 .46 .33
Prps1
KLA  ATP  ATP+KLA
 NM_021463 phosphoribosyl pyrophosphate synthetase 1 (Prps1), mRNA [NM_021463] KLA .82 .83 .85 .70 .56 .42 .52
ATP 1.00 1.03 1.20 1.21 1.08 .67 .54
KLA/ATP .85 .86 .90 .86 .68 .52 .42
Prps1l1
KLA  ATP  ATP+KLA
 NM_029294 phosphoribosyl pyrophosphate synthetase 1-like 1 (Prps1l1), mRNA [NM_029294] KLA 1.05 .97 .99 1.03 1.04 1.00 1.04
ATP .99 .96 1.04 1.05 1.05 .99 1.07
KLA/ATP .99 1.03 1.07 1.00 1.01 1.01 1.09
Prps2
KLA  ATP  ATP+KLA
 NM_026662 phosphoribosyl pyrophosphate synthetase 2 (Prps2), mRNA [NM_026662] KLA .85 .85 .88 .76 .60 .45 .43
ATP 1.00 1.13 1.18 1.19 .79 .35 .37
KLA/ATP .85 .93 .88 .83 .62 .38 .24
Prune
KLA  ATP  ATP+KLA
 AK053118 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030004J02 product:unclassifiable, full insert sequence [AK053118] KLA .28 .29 .31 .43 .57 .78 .62
ATP .83 .70 .61 .50 .82 1.02 .73
KLA/ATP .20 .19 .27 .33 .88 .64 .63
Prune
KLA  ATP  ATP+KLA
 NM_173347 prune homolog (Drosophila) (Prune), mRNA [NM_173347] KLA .61 .60 .64 .58 .70 .77 .92
ATP 1.13 1.27 .87 .72 2.26 1.50 1.31
KLA/ATP .67 .69 .53 .53 1.42 1.46 1.29
Rpo1-1
KLA  ATP  ATP+KLA
 NM_009085 RNA polymerase 1-1 (Rpo1-1), mRNA [NM_009085] KLA .77 .81 .81 .91 .90 .68 .86
ATP 1.03 .92 .86 .94 2.06 1.70 .91
KLA/ATP .82 .85 .86 .65 1.41 1.49 .92
Rpo1-2
KLA  ATP  ATP+KLA
 AK052672 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630020H17 product:RNA polymerase 1-2 (128 kDa subunit), full insert sequence. [AK052672] KLA 1.03 .94 1.03 1.01 .97 .97 1.00
ATP 1.01 1.00 .99 .94 1.02 .94 1.00
KLA/ATP 1.04 .98 .97 .89 1.01 1.02 .93
Rpo1-2
KLA  ATP  ATP+KLA
 NM_009086 RNA polymerase 1-2 (Rpo1-2), mRNA [NM_009086] KLA 1.64 1.60 1.10 .82 .62 .63 .98
ATP 1.04 1.17 .99 .79 .50 .59 .91
KLA/ATP 1.21 1.54 1.15 .76 .37 .61 .50
Rpo1-3
KLA  ATP  ATP+KLA
 NM_009087 RNA polymerase 1-3 (Rpo1-3), transcript variant 1, mRNA [NM_009087] KLA 1.00 .98 .86 .90 .95 .76 .93
ATP 1.07 1.09 1.20 1.26 1.26 1.12 .99
KLA/ATP .89 1.04 1.10 1.08 1.01 .71 .67
Rpo1-3
KLA  ATP  ATP+KLA
 NM_181730 RNA polymerase 1-3 (Rpo1-3), transcript variant 2, mRNA [NM_181730] KLA 1.06 1.17 1.07 1.08 .99 1.04 .98
ATP .93 .97 1.12 1.27 1.36 1.31 .82
KLA/ATP 1.02 1.06 1.20 1.31 1.28 1.32 .90
Rpo1-4
KLA  ATP  ATP+KLA
 NM_009088 RNA polymerase 1-4 (Rpo1-4), mRNA [NM_009088] KLA .75 .68 .58 .60 .46 .53 1.06
ATP 1.07 .98 1.22 1.00 .69 .74 .75
KLA/ATP .68 .65 .76 .61 .45 .34 .49
Rrm1
KLA  ATP  ATP+KLA
 AK049601 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001L22 product:ribonucleotide reductase M1, full insert sequence. [AK049601] KLA .99 .96 1.17 1.00 1.00 .88 .97
ATP 1.07 .98 .94 .96 .92 .86 .99
KLA/ATP 1.00 1.03 1.00 .96 1.02 1.00 .95
Rrm1
KLA  ATP  ATP+KLA
 NM_009103 ribonucleotide reductase M1 (Rrm1), mRNA [NM_009103] KLA .47 .46 .38 .28 .18 .21 .17
ATP .97 1.01 1.06 .97 .65 .27 .18
KLA/ATP .46 .42 .39 .36 .23 .16 .11
Rrm2
KLA  ATP  ATP+KLA
 NM_009104 ribonucleotide reductase M2 (Rrm2), mRNA [NM_009104] KLA .32 .27 .23 .17 .13 .13 .12
ATP .98 1.00 1.17 1.28 .66 .20 .08
KLA/ATP .28 .25 .30 .30 .23 .13 .08
Rrm2b
KLA  ATP  ATP+KLA
 NM_199476 ribonucleotide reductase M2 B (TP53 inducible) (Rrm2b), mRNA [NM_199476] KLA .93 .90 .89 .95 .97 1.00 1.13
ATP .96 .95 .95 .87 .75 .80 .90
KLA/ATP .84 .85 .89 .84 .78 .78 .88
Twistnb
KLA  ATP  ATP+KLA
 NM_172253 TWIST neighbor (Twistnb), mRNA [NM_172253] KLA 1.30 1.25 1.07 .87 .82 .80 1.03
ATP 1.10 1.00 .92 .87 1.26 1.07 .94
KLA/ATP 1.29 1.21 1.09 .82 .79 .85 .59
Uox
KLA  ATP  ATP+KLA
 NM_009474 urate oxidase (Uox), mRNA [NM_009474] KLA .98 .99 1.00 1.00 1.02 1.02 1.01
ATP .99 .98 .98 1.05 1.02 1.01 1.05
KLA/ATP 1.02 1.00 1.02 1.04 1.02 .99 1.02
Xdh
KLA  ATP  ATP+KLA
 NM_011723 xanthine dehydrogenase (Xdh), mRNA [NM_011723] KLA 1.82 1.90 2.33 2.06 2.49 2.56 1.77
ATP 1.02 1.15 .98 1.10 1.06 1.02 1.42
KLA/ATP 2.00 2.00 2.02 2.11 1.27 1.56 1.92
Znrd1
KLA  ATP  ATP+KLA
 NM_023162 zinc ribbon domain containing, 1 (Znrd1), mRNA [NM_023162] KLA 1.04 1.12 1.28 1.43 1.67 1.76 1.39
ATP 1.01 1.08 1.13 1.34 .81 1.14 1.30
KLA/ATP 1.00 1.16 1.22 1.53 1.21 1.74 1.97